SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019049
Filing Date
2023-11-14
Accepted
2023-11-14 16:40:45
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230930x10q.htm   iXBRL 10-Q 1192729
2 EX-10.1 tmb-20230930xex10d1.htm EX-10.1 97249
3 EX-31.1 tmb-20230930xex31d1.htm EX-31.1 10603
4 EX-31.2 tmb-20230930xex31d2.htm EX-31.2 10451
5 EX-32.1 tmb-20230930xex32d1.htm EX-32.1 6685
6 EX-32.2 tmb-20230930xex32d2.htm EX-32.2 6362
  Complete submission text file 0001558370-23-019049.txt   4791014

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20230930.xsd EX-101.SCH 31513
8 EX-101.CAL tmb-20230930_cal.xml EX-101.CAL 32685
9 EX-101.DEF tmb-20230930_def.xml EX-101.DEF 121169
10 EX-101.LAB tmb-20230930_lab.xml EX-101.LAB 304728
11 EX-101.PRE tmb-20230930_pre.xml EX-101.PRE 223646
52 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230930x10q_htm.xml XML 764738
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 231407301
SIC: 2834 Pharmaceutical Preparations